tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Innate Pharma Reports Share and Voting Rights Update as of September 1, 2025

Story Highlights
  • Innate Pharma announced its share and voting rights details as of September 1, 2025.
  • The update includes 92,185,473 ordinary shares and 93,944,368 exercisable voting rights.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Innate Pharma Reports Share and Voting Rights Update as of September 1, 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Innate Pharma SA ( (FR:IPH) ) just unveiled an announcement.

On September 2, 2025, Innate Pharma S.A. announced its total number of shares and voting rights as of September 1, 2025. The company reported 92,185,473 ordinary shares, 6,419 Preferred Shares 2016, and 7,581 Preferred Shares 2017, with a total of 93,962,943 theoretical voting rights and 93,944,368 exercisable voting rights. This update ensures market transparency and informs stakeholders about the company’s current shareholding structure.

The most recent analyst rating on (FR:IPH) stock is a Hold with a EUR3.10 price target. To see the full list of analyst forecasts on Innate Pharma SA stock, see the FR:IPH Stock Forecast page.

More about Innate Pharma SA

Innate Pharma S.A. is a global, clinical-stage biotechnology company focused on developing immunotherapies for cancer patients. The company leverages the innate immune system through its proprietary ANKET® platform, Antibody Drug Conjugates, and monoclonal antibodies. Innate Pharma collaborates with biopharmaceutical companies such as Sanofi and AstraZeneca and is listed on Euronext Paris and Nasdaq.

Average Trading Volume: 163,236

Technical Sentiment Signal: Hold

Current Market Cap: €170M

Find detailed analytics on IPH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1